-
Bangyao Biological Appoints Ms. Li Fuying as Vice President & Head of Pharmaceutical Affairs Department
Time of Update: 2021-09-20
Li Fuying as the company's vice president & head of the pharmaceutical administration team, who will be responsible for the domestic and international registration of Bangyao's pipeline products .
-
Hanyu Pharmaceutical Etibatide passed the consistency evaluation of generic drugs
Time of Update: 2021-09-20
To reduce the combined end-point rate of death, new myocardial infarction or the need for emergency interventional therapy .
-
Standardize informed notification to let parents clearly choose vaccines
Time of Update: 2021-09-19
Fulfill the lawful and informed notification to fully protect the lives and health of children In order to further strengthen vaccine management, ensure vaccine quality and supply, standardize vaccination, and protect public health, China formally implemented the "People's Republic of China Vaccine Management Law" on December 1, 2019, which regulates the obligation of medical and health personnel to be informed .
-
Sales of 5 drugs may reach US$8.6 billion in the next five years!
Time of Update: 2021-09-19
At present, as the FDA's months-long safety investigation of Pfizer Xeljanz has come to an end, it seems that other JAK inhibitors are expected to be re-approved by the FDA at the end of the year, including another highly anticipated atopic dermatitis drug abrocitinib .
-
Clinical trial requirements for clinical drug registration management
Time of Update: 2021-09-19
Its purpose is to preliminarily evaluate the therapeutic effect and safety of the drug on patients with target indications, and also to provide a basis for the design of phase III clinical trials and the determination of the dosage regimen .
-
Qinghai Province Drug Quality Sampling Inspection Results Announced 55 Batches of Drugs All Meet Drug Standards
Time of Update: 2021-09-19
The original text is as follows:The original text is as follows:Qinghai Province Drug Quality Sampling Inspection Information Announcement (Phase 1, 2021)No.
-
From the crisis of trust to the ups and downs of global competition in the past three years, China's vaccine industry has changed
Time of Update: 2021-09-19
At the same time as the research and development progress, Watson Biotech announced the successful delivery of China's first mRNA new crown vaccine factory in early September 2021 .
-
A new class of hypoglycemic drugs!
Time of Update: 2021-09-19
The chemical structure of imeglimin (picture source: Wikipedia)Imeglimin is a first-in-class drug with a new mechanism of action (MOA) targeting mitochondrial dysfunction, which can improve insulin secretion disorders and insulin sensitivity, both of which It is a key factor leading to type 2 diabetes .
-
PD-L1 Inhibitors and Urothelial Carcinoma-Love is easy and difficult to defend
Time of Update: 2021-09-19
In less than a year, based on the results of IMvigor 210 study cohort 1, the FDA accelerated the approval of atelizumab for the first-line treatment of advanced UC on April 18, 2017 .
-
Current status of product development of transdermal drug delivery preparations
Time of Update: 2021-09-19
Compared with traditional methods of administration, transdermal absorption preparations have the following advantages: they can produce durable, constant and controllable blood drug concentration, thereby reducing adverse reactions; avoiding the first pass effect of the liver and improving the bioavailability of the drug; The pain of injection medication; patients can take the medication by themselves, and the medication can be stopped in time if there is a problem, which is convenient to use .
-
6 categories of drugs "on the list" National Health Commission adjusts "Key Monitoring Drug List"
Time of Update: 2021-09-19
This six drugs comprising: an auxiliary drug, anti -tumor drugs, antimicrobials, proton pump inhibitors, glucocorticoids, parenteral nutrition drugs .
-
China Food and Drug Administration: Thermo Fisher Scientific and Rejuvenation Medical Devices are recalling a batch of medical devices
Time of Update: 2021-09-19
actively recalled the disposable blood transfusion set with needlesChangzhou Huichun Medical Equipment Co.
reported that the disposable blood transfusion set with needles produced by this company has leaked, and it is now actively recalled.
-
Livzon's first hypoglycemic biologic medicine is here!
Time of Update: 2021-09-19
On September 13th, Livzon submitted a clinical application for a new class of 3.
In fields such as drug-like drugs, smeglutide injection is expected to become a new breakthrough for the company in the field of hypoglycemia .
-
Chinese pharmaceutical subsidiary vildagliptin tablets obtained drug registration certificate
Time of Update: 2021-09-19
On September 13, China Pharmaceuticals issued an announcement stating that its wholly-owned subsidiary General Sanyo received a "drug registration certificate" for vildagliptin tablets approved and issued by the State Drug Administration for the treatment of type 2 diabetes .
-
The formula pellets rose fiercely, and the two leaders combined to break 7 billion in half a year!
Time of Update: 2021-09-19
It is mentioned in the semi-annual report that with the company's increased recognition of the quality controllability of traditional Chinese medicine formula granules and the operation mode of dispensing machines, the business of this sector has developed rapidly and the gross profit margin has increased steadily .
-
On the Science and Technology Innovation Board, another biopharmaceutical company that has not yet made a profit!
Time of Update: 2021-09-19
At present, the phase III clinical trial of paclitaxel micelles combined with cisplatin for the first-line treatment of advanced non-small cell lung cancer has been completed and is under review and approval of new drug registration and marketing.
-
Interpretation of the in-depth analysis of the latest national version of the national drug renewal rules
Time of Update: 2021-09-19
The "three stability" of the national procurement renewal varieties is the foundation!The "Notice" requires that "focus on stabilizing market expectations, stabilizing price levels, and stabilizing clinical medications, and in compliance with laws and regulations, fair and open determination of selected companies, selected prices, agreed procurement quantities and procurement agreement periods, and promote the normalization and institutionalization of centralized and volume procurement mechanisms Operation, and guide the society to form long-term stable expectations .
-
43 local people diagnosed with the latest epidemic prevention requirements of the new crown drugstore are here!
Time of Update: 2021-09-19
On September 13, the official microblog of the First Affiliated Hospital of Xiamen University issued a notice that the hospital found during a routine active screening on September 12 that a third-party company’s logistics service personnel had a positive nucleic acid test result, due to the need for epidemic prevention and control , The hospital will implement closed management immediately and suspend outpatient and emergency medical services .
-
Guangdong Union Qingkailing and other 58 drugs with bulk purchases began to solicit opinions
Time of Update: 2021-09-19
Purchase cycle and purchase agreement(1) The procurement cycle for the drug alliance area of this product range is to 202*year*month*day, calculated from the actual implementation date of the selected result .
-
Liver cirrhosis leads to 8 families with rare genetic diseases diagnosed one after another
Time of Update: 2021-09-19
An exception indicators pull the family of rare diseases When he came to the Liver Disease Center of Ditan Hospital , Chief Physician Yang Song prescribed Lao Zhang routine hepatitis B and C screening, and the results were all negative .
